Physician profile
Jillian Johnson
NPI 1740922608
$3,178.14
in general payments reported to CMS, 2019-2025
17 companies · $1,250 in 2025
The $1,250 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $203 · 2024: $1,726 · 2025: $1,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,978 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,978.16 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $826.53 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $558.43 | 2024-2025 | Sotyktu |
| Ucb, INC. | $336.66 | 2024-2025 | Bimzelx |
| Genzyme Corporation | $336.42 | 2024-2025 | |
| Galderma Laboratories, L.P. | $141.71 | 2025 | Nemluvio |
| Janssen Biotech, INC. | $124.31 | 2024-2025 | Tremfya, Simponi, Stelara |
| Novartis Pharmaceuticals Corporation | $123.27 | 2024-2025 | |
| Incyte Corporation | $121.97 | 2024-2025 | Opzelura |
| Organogenesis INC. | $121.86 | 2025 | Apligraf |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.86 | 2024-2025 | Spevigo |
| Sun Pharmaceutical Industries INC. | $101.04 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $99.42 | 2024 | Tremfya |
| Lilly USA, LLC | $97.41 | 2024-2025 | Ebglyss, Taltz |
| Leo Pharma INC. | $27.42 | 2025 | Spevigo |
| Genentech USA, INC. | $25.19 | 2023 | Erivedge |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $19.80 | 2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $14.84 | 2023 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.